Common Sense Health

ApoB: The Truth

19 min · 1. juni 2026
episode ApoB: The Truth cover

Beskrivelse

The conversation delves into the rediscovery of ApoB as a significant cardiovascular marker and its suspiciously aligned timing with pharmaceutical profit motives. It explores the comparison between ApoB and LDLC, the rise of statins, the emergence of PCSK9 inhibitors, the controversy around ApoB, the context of metabolic dysfunction, and the pharmaceutical vs. metabolic approach to ApoB. It concludes with the distinction between treating a number and treating a disease. Takeaways * ApoB has become a significant cardiovascular marker * The timing of ApoB's rediscovery is suspiciously aligned with pharmaceutical profit motives Chapters * 00:00 Treating a Number vs. Treating a Disease

Kommentarer

0

Vær den første til at kommentere

Tilmeld dig nu og bliv en del af Common Sense Health-fællesskabet!

Kom i gang

1 måned kun 9 kr.

Derefter 99 kr. / måned · Opsig når som helst.

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

Alle episoder

299 episoder